Analgesics in Tanzania in 2026 records strong current value growth as population expansion, urbanisation and rising chronic pain needs sustain demand for accessible pain relief. Systemic analgesics remains both the largest and best performing category, supported by widespread use of paracetamol and NSAIDs, while price sensitivity reinforces demand for affordable generics and value-oriented brands. GSK Consumer Healthcare retains the lead through Panadol’s strong recognition, extensive distribution and established reputation for pain and fever relief, although competition is becoming more dispersed. Gofen retains a premium position through perceived efficacy, while lower-priced alternatives remain important as import and logistics costs increase pressure on affordability. Pharmacies remain central to purchasing through broad product availability and professional advice, with e-commerce providing complementary access for familiar analgesics. Looking ahead, population growth and the rising incidence of conditions such as arthritis and back pain are expected to sustain analgesics demand. Interest in natural and herbal pain relief is anticipated to broaden portfolios alongside synthetic products, while Tanzania’s heavy reliance on imported medicines leaves availability exposed to global supply disruption. Local production partnerships and diversified sourcing are therefore poised to become increasingly important to maintaining reliable and affordable pain relief.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Tanzania with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Tanzania, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Tanzania report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Tanzania?
- Which are the leading brands in Analgesics in Tanzania?
- How are products distributed in Analgesics in Tanzania?
- How has the regulatory and operating environment for Analgesics changed in Tanzania?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Affordable analgesics sustain demand across a price-sensitive market
Supply-chain pressures accelerate trade-down to generics and local products
E-commerce broadens painkiller access and supports stock availability
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Pharmacy access expected to support sustained demand for pain relief
Natural preferences and price sensitivity poised to reshape product portfolios
Import dependency expected to heighten the need for supply resilience
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
GSK retains the lead as distribution and brand trust support Panadol
Gofen competes through perceived efficacy and retailer engagement
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies dominate pain relief through trusted access and broad availability
Online pharmacies extend access while remaining complementary to physical retail
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!